Firsthand experience
Meet Timothy, who gives us a personal perspective about his experience as a VYVGART Hytrulo clinical study participant.*
*Adult living with CIDP, on VYVGART Hytrulo, and paid spokesperson of argenx.
Tune in on Tuesday, October 1st, at either 2 PM or 7 PM EDT to learn more about VYVGART Hytrulo from special guests with firsthand experience. Listen to experts reveal the science behind the treatment and meet one of the people who make our support program special.
Secure your spot for Breaking Through Today to discover even more about VYVGART Hytrulo.
Keep an eye on your inbox so you don’t miss out on important updates about the event. You’ll also be receiving a call from a VYVGART Educator within a few business days.
Keep an eye on your inbox so you don’t miss out on important updates about the event.
You’re now signed up to receive more information and updates about VYVGART.
You’re now signed up to receive more information and updates about VYVGART. You’ll also be receiving a call from a VYVGART Educator [within a few business days].
Help at every step in understanding your VYVGART treatment
My VYVGART Path is a Patient Support Program that provides personalized support from a Nurse Case Manager and committed support team.
Do not use VYVGART HYTRULO if you have a serious allergy to efgartigimod alfa, hyaluronidase, or any of the other ingredients in VYVGART HYTRULO. VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.
Tell your doctor if you have signs or symptoms of an infection, allergic reaction, or infusion-related reaction. These can happen while you are receiving your VYVGART HYTRULO treatment or afterward. Your doctor may need to pause or stop your treatment. Contact your doctor immediately if you have signs or symptoms of a serious allergic reaction.
The most common side effects in efgartigimod-alfa-fcab-treated patients were respiratory tract infection, headache, and urinary tract infection. Additional common side effects with VYVGART HYTRULO are injection site reactions, including rash, redness of the skin, itching sensation, bruising, pain, and hives.
These are not all the possible side effects of VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to the US Food and Drug Administration at 1-800-FDA-1088.
VYVGART HYTRULO is a prescription medicine used for the treatment of adult patients with chronic inflammatory demyelinating polyneuropathy (CIDP)
Do not use VYVGART HYTRULO if you have a serious allergy to efgartigimod alfa, hyaluronidase, or any of the other ingredients in VYVGART HYTRULO. VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.
Tell your doctor if you have signs or symptoms of an infection, allergic reaction, or infusion-related reaction. These can happen while you are receiving your VYVGART HYTRULO treatment or afterward. Your doctor may need to pause or stop your treatment. Contact your doctor immediately if you have signs or symptoms of a serious allergic reaction.
The most common side effects in efgartigimod-alfa-fcab-treated patients were respiratory tract infection, headache, and urinary tract infection. Additional common side effects with VYVGART HYTRULO are injection site reactions, including rash, redness of the skin, itching sensation, bruising, pain, and hives.
These are not all the possible side effects of VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to the US Food and Drug Administration at 1-800-FDA-1088.
VYVGART HYTRULO is a prescription medicine used for the treatment of adult patients with chronic inflammatory demyelinating polyneuropathy (CIDP)